Check out – It’s our favorite image for Pink October this year!
10 / 11 / 2023
More than a month, more than a mission, but one of our commitments that we reaffirm every year. Fighting cancer including breast cancer (BC), and especially triple negative BC (TNBC) is at the heart of our activities.
TNBC is the most malignant subtype of BC with a poor prognosis. Because it’s highly heterogeneous while current treatment options are limited to surgery, adjuvant chemotherapy and radiotherapy, and a fraction of patients miss the surgical window at diagnosis, targeted therapies represent promising options but further research efforts are needed.
Interestingly, immunotherapy - although insufficient when administered alone - is making important progress, so immunotherapy-based combination strategies hold good promise.
Let’s mobilize to raise awareness and dig into breast cancer research together! Because we believe that further research advances in identifying biomarkers and targets will increasingly forge the development of targeted and individualized medicine for more hope and better clinical outcomes.